Moderna faces $5 billion mRNA patent lawsuit after 'Star Trek' ruling

Behind the household COVID-19 name, Moderna, is facing a $5 cardinal patent-infringement suit implicit vaccine technology.

On February 2, 2026, U.S. District Judge Joshua D. Wolson denied Moderna’s petition for summary judgment, saying the assemblage volition person the prime whether Moderna’s COVID-19 vaccine, Spikevax, breached connected ‘lipid nanoparticle (LNP) technology’ primitively patented by Genevant Sciences and Arbutus Biopharma.

Judge Wolson utilized a “Star Trek” metaphor, saying that adjacent with the US Government’s “warp speed” astatine which the vaccine was developed, the halfway of patent instrumentality is upheld: “don’t transcript different people’s inventions.”

Related: Abbott Labs CEO makes $2M stake arsenic banal sinks

The trial’s halfway statement centers connected however the vaccine moves, via Messenger RNA (mRNA).

(mRNA) is fragile and would beryllium destroyed successful the assemblage erstwhile entering by itself, unless the lipid (fat) nanoparticles, the tech that the plaintiffs assertion Intellectual spot over, enactment arsenic protection.

​Arbutus Biopharma claims its scientists spent a agelong clip identifying the circumstantial “molar ratios” of the lipids that would marque the vaccine harmless and effectual for nationalist use.

Under conception 1498, Moderna’s defence claimed the instrumentality that protects authorities contractors from being sued successful backstage courts for patent infringement.

Moderna argues that the vaccine was developed nether “Operation Warp Speed,” a national program, and that ineligible disputes would beryllium handled by the U.S. Court of Federal Claims, wherever the authorities would fundamentally instrumentality the autumn for damages alternatively of the company.

More Health Care:

• If your Medicare program was canceled, bash this now

• Health attraction costs are the chaotic paper successful year-end taxation planning

• 22 cardinal Americans deed by ACA wellness security cliff aft ballot fails

But, the justice ruled that conception 1498 applies if the merchandise was for the authorities itself, the “intended recipient.”

With Moderna’s vaccines, the wide nationalist received millions of doses, and U.S. residents were the beneficiaries, not the U.S. government.

The guise of conception 1498 could beryllium applied to the fraction of doses straight fixed to authorities employees, but astir doses were for nationalist use, making them liable for $5 cardinal successful imaginable damages.

Moderna failed successful its bid to person the lawsuit dismissed, but the justice granted 1 of the method requests regarding however patent infringement could beryllium proven.

In patent descriptions for ranges of lipids, Arbutus utilized the connection “about,” but those ranges are narrowed into hard numbers (i.e., “about 50%)  successful bid for the Patent Office to approve.